Basic Search  |  Geographic Searches  |  Advanced Search | Megadeals

Subsidy Tracker Parent Company Summary

Parent Company Name: GlaxoSmithKline
Ownership Structure: publicly traded (ticker symbol LSE: GSK)
Headquartered in: United Kingdom
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Subsidy SummarySubsidy ValueNumber of Awards
State/Local$65,258,90338
Federal (grants and allocated tax credits)$6,935,5436
TOTAL$72,194,44644
Loan / Bailout SummaryTotal Face ValueNumber of Awards
State/Local loans, bond financing and venture capital$00
Federal loans, loan guarantees and bailout assistance (not including repayments)$00
TOTAL$00
Time Period for State and Local Awards: Earliest year of data: 2000. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2012.
Time Period for Federal Awards: FY2000 to the present
Notes: Dollar totals do not include awards for which no subsidy value is disclosed.
Links: For a summary of this company's regulatory violations see its Violation Tracker summary page here.

For an overview of this company's accountability track record, read its Corporate Rap Sheet here.

For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.

Top 5 States for state/local awardsTotal Subsidy $Number of Awards
North Carolina$35,763,17810
Pennsylvania$23,210,69112
New York$5,103,88110
Washington$935,6324
Montana$240,0001
All other$5,5211

Individual Subsidy Records:

Click on the company name for more information on each subsidy award.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyLocationSubsidy SourceYear sort icon . Subsidy ValueLoan/Bailout ValueType of Subsidy
GLAXOSMITHKLINE & Stiefel Laboratories Inc.New Yorklocal2020$588,821tax credit/rebate
GLAXOSMITHKLINE LLCPennsylvaniastate2020$3,388,900tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.New Yorklocal2019$556,419tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.New YorkLocal2018$494,593tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.New Yorklocal2017$540,625tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc.North Carolinastate2016$4,121,650tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.New Yorklocal2016$534,097tax credit/rebate
GlaxoSmithKline, LLC (f/k/a SmithKline Beecham Corporation)Pennsylvaniastate2015$2,269,398tax credit/rebate
GlaxoSmithkline Holdings Americas, Inc. North Carolinastate2015$171,518tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc.North Carolinastate2015$8,524,608tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.New Yorklocal2015$534,097tax credit/rebate
GlaxoSmithKline, LLC (f/k/a SmithKline Beecham Corporation)Pennsylvaniastate2014$3,353,317tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.New Yorklocal2014$432,501tax credit/rebate
GlaxoSmithKline, LLC ( f/k/a SmithKline Beecham Corporation)Pennsylvaniastate2013$2,357,066tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc. North Carolinastate2013$4,414,142tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc. North Carolinastate2013$167,753tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc. North Carolinastate2013$4,414,142tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.New Yorklocal2013$470,487tax credit/rebate; property tax abatement
GlaxoSmithKline, LLC ( f/k/a SmithKline Beecham Corporation)Pennsylvaniastate2012$4,247,696tax credit/rebate
GlaxoSmithKline Holdings Americas , Inc.North Carolinastate2012$4,025,543tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.New Yorklocal2012$464,160tax credit/rebate; property tax abatement
GlaxoSmithKline United Statesfederal2012$4,011,709federal grant
GlaxoSmithKlineUnited Statesfederal2012$729,692federal grant
GlaxoSmithKline Holdings Americas , Inc. North Carolinastate2012$4,025,543tax credit/rebate
GlaxoSmithKline BiologicalsMontanastate2011$240,000grant/loan hybrid program
SmithKline Beecham Corporation DBA GlaxoSmithKlinePennsylvaniastate2011$951,581tax credit/rebate
GlaxoSmithkline Holdings Americas , Inc.North Carolinastate2011$4,039,279tax credit/rebate
GLAXOSMITHKLINE & Stiefel Laboratories Inc.New Yorklocal2011$488,081tax credit/rebate; property tax abatement
SmithKline Beecham Corporation DBA GlaxoSmithKlinePennsylvaniastate2010$435,635tax credit/rebate
SmithKline Beecham Corporation DBA GlaxoSmithKlinePennsylvaniastate2008$2,990,917tax credit/rebate
GLAXOWELLCOME INCTennesseelocal2008$5,521property tax abatement
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICAWashingtonstate2007$116,504tax credit/rebate
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICAWashingtonstate2006$397,686tax credit/rebate
SMITHKLINE BEECHAM RESEARCH COUnited Statesfederal2006$620,077federal grant
SMITHKLINE BEECHAM RESEARCH COUnited Statesfederal2006$592,421federal grant
GlaxoSmithKline Beecham CorpNorth Carolinastate2005$1,859,000grant
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICAWashingtonstate2004$168,442tax credit/rebate
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICAWashingtonstate2004$253,000tax credit/rebate
GLAXOSMITHKLINE, INCUnited Statesfederal2001$606,644federal grant
SMITHKLINE BEECHAM CORPORATIONUnited Statesfederal2000$375,000federal grant
GlaxoSmithKline Biologicals North AmericaPennsylvaniastate$316,181training reimbursement
GlaxoSmithKlinePennsylvaniastate$200,000training reimbursement
GlaxoSmithKline Biologicals North America dba CorixaPennsylvaniastate$1,350,000tax credit/rebate
GlaxoSmithKline Biologicals North America dba CorixaPennsylvaniastate$1,350,000grant